136 related articles for article (PubMed ID: 2187838)
1. T-cell allorecognition of HLA class II.
Termijtelen A
Hum Immunol; 1990 May; 28(1):1-10. PubMed ID: 2187838
[No Abstract] [Full Text] [Related]
2. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
3. Structural aspects of allorecognition.
Lechler R; Lombardi G
Curr Opin Immunol; 1991 Oct; 3(5):715-21. PubMed ID: 1755989
[TBL] [Abstract][Full Text] [Related]
4. Proliferative responses to allogeneic HLA class I peptides.
Paraoan MT; Sells RA; Bakran A; Hammad A; Christmas SE
Transplant Proc; 2001; 33(1-2):334-5. PubMed ID: 11266848
[No Abstract] [Full Text] [Related]
5. A speculative view of the multicomponent nature of T cell antigen recognition.
Goverman J; Hunkapiller T; Hood L
Cell; 1986 May; 45(4):475-84. PubMed ID: 3085952
[No Abstract] [Full Text] [Related]
6. Individual variation in alloresponsiveness and the molecular basis of allorecognition.
Batchelor JR; Kaminski E; Lombardi G; Goldman JM; Lechler RI
Hum Immunol; 1990 Jun; 28(2):96-103. PubMed ID: 2141014
[No Abstract] [Full Text] [Related]
7. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.
Vella JP; Spadafora-Ferreira M; Murphy B; Alexander SI; Harmon W; Carpenter CB; Sayegh MH
Transplantation; 1997 Sep; 64(6):795-800. PubMed ID: 9326400
[TBL] [Abstract][Full Text] [Related]
8. Self peptide requirement for class II major histocompatibility complex allorecognition.
Demotz S; Sette A; Sakaguchi K; Buchner R; Appella E; Grey HM
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8730-4. PubMed ID: 1924332
[TBL] [Abstract][Full Text] [Related]
9. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
10. [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants].
Wollman EE; Lepage V; Delima M; Fradelizi D; Degos L; Dausset J
C R Seances Acad Sci D; 1980 Nov; 291(9):757-61. PubMed ID: 6162584
[TBL] [Abstract][Full Text] [Related]
11. The nature of allorecognition.
Krensky AM; Clayberger C
Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):898-903. PubMed ID: 7922230
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution in a cytochrome c T cell stimulatory peptide changes the MHC restriction element from one isotype (I-Ak) to another (I-Ek).
Kelner GS; Jenkins MK; Jemmerson R
Mol Immunol; 1993 Apr; 30(6):569-75. PubMed ID: 7683749
[TBL] [Abstract][Full Text] [Related]
13. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
Germain RN
Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
[No Abstract] [Full Text] [Related]
14. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes.
Lombardi G; Lechler R
Ann Ist Super Sanita; 1991; 27(1):7-14. PubMed ID: 1958030
[TBL] [Abstract][Full Text] [Related]
16. Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens.
Levy RB; Jones M; Streilein JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):360-1. PubMed ID: 8438335
[No Abstract] [Full Text] [Related]
17. Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.
Iwata M; Yagihashi A; Roat MI; Zeevi A; Iwaki Y; Thoft RA
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):3991-4000. PubMed ID: 7960581
[TBL] [Abstract][Full Text] [Related]
18. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
[TBL] [Abstract][Full Text] [Related]
19. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
[TBL] [Abstract][Full Text] [Related]
20. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
